

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.68128615 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.67053110 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.51223255 |
| 4 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.33723054 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.08971595 |
| 6 | negative regulation of interleukin-12 production (GO:0032695) | 5.02463261 |
| 7 | positive regulation of interferon-alpha production (GO:0032727) | 5.00404851 |
| 8 | regulation of activation of Janus kinase activity (GO:0010533) | 4.95019196 |
| 9 | T-helper 1 type immune response (GO:0042088) | 4.83191463 |
| 10 | positive regulation of antigen processing and presentation (GO:0002579) | 4.80460040 |
| 11 | regulation of interferon-alpha production (GO:0032647) | 4.71770217 |
| 12 | positive regulation of interleukin-12 production (GO:0032735) | 4.64164763 |
| 13 | neutrophil activation (GO:0042119) | 4.41846511 |
| 14 | positive regulation of mast cell activation (GO:0033005) | 4.37759389 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 4.37678798 |
| 16 | granulocyte activation (GO:0036230) | 4.32657863 |
| 17 | cellular response to type I interferon (GO:0071357) | 4.29261902 |
| 18 | type I interferon signaling pathway (GO:0060337) | 4.29261902 |
| 19 | response to type I interferon (GO:0034340) | 4.23783557 |
| 20 | detection of other organism (GO:0098543) | 4.23664153 |
| 21 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.23001028 |
| 22 | response to peptidoglycan (GO:0032494) | 4.22218233 |
| 23 | negative regulation of interleukin-17 production (GO:0032700) | 4.19184514 |
| 24 | regulation of antigen processing and presentation (GO:0002577) | 4.18860365 |
| 25 | positive regulation of mast cell degranulation (GO:0043306) | 4.14967440 |
| 26 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.14967440 |
| 27 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.13391285 |
| 28 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.12675759 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 4.04905897 |
| 30 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.03171416 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.02940418 |
| 32 | negative regulation of cell killing (GO:0031342) | 4.02940418 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.97101809 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.92933237 |
| 35 | cellular extravasation (GO:0045123) | 3.92619686 |
| 36 | detection of bacterium (GO:0016045) | 3.90282031 |
| 37 | regulation of RIG-I signaling pathway (GO:0039535) | 3.88763686 |
| 38 | regulation of mast cell degranulation (GO:0043304) | 3.88370351 |
| 39 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.84497841 |
| 40 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.84132276 |
| 41 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.81109845 |
| 42 | cellular response to zinc ion (GO:0071294) | 3.77337474 |
| 43 | * positive regulation of type 2 immune response (GO:0002830) | 3.76847441 |
| 44 | cellular response to exogenous dsRNA (GO:0071360) | 3.71431906 |
| 45 | regulation of mast cell activation (GO:0033003) | 3.68977670 |
| 46 | regulation of memory T cell differentiation (GO:0043380) | 3.67634927 |
| 47 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.67039331 |
| 48 | natural killer cell mediated immunity (GO:0002228) | 3.67039331 |
| 49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66870298 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.66870298 |
| 51 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.65976801 |
| 52 | NIK/NF-kappaB signaling (GO:0038061) | 3.61997774 |
| 53 | * positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.60933054 |
| 54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.59797782 |
| 55 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.59234698 |
| 56 | regulation of interleukin-12 production (GO:0032655) | 3.58816646 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 3.57602573 |
| 58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.57602573 |
| 59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.57602573 |
| 60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.57602573 |
| 61 | modulation by symbiont of host immune response (GO:0052553) | 3.57602573 |
| 62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.57602573 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55610826 |
| 64 | detection of biotic stimulus (GO:0009595) | 3.55595723 |
| 65 | cellular response to interferon-beta (GO:0035458) | 3.54976248 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 3.54826286 |
| 67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.54269389 |
| 68 | monocyte chemotaxis (GO:0002548) | 3.53206368 |
| 69 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.53107855 |
| 70 | * positive regulation of T-helper cell differentiation (GO:0045624) | 3.52752114 |
| 71 | response to muramyl dipeptide (GO:0032495) | 3.51996921 |
| 72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.47588511 |
| 73 | eosinophil chemotaxis (GO:0048245) | 3.47292685 |
| 74 | macrophage activation (GO:0042116) | 3.46848188 |
| 75 | positive regulation of interferon-beta production (GO:0032728) | 3.45911907 |
| 76 | positive regulation of leukocyte degranulation (GO:0043302) | 3.43524492 |
| 77 | defense response to protozoan (GO:0042832) | 3.43040862 |
| 78 | negative thymic T cell selection (GO:0045060) | 3.42886653 |
| 79 | regulation of hypersensitivity (GO:0002883) | 3.42858224 |
| 80 | regulation of immunoglobulin secretion (GO:0051023) | 3.42755592 |
| 81 | regulation of T-helper 1 type immune response (GO:0002825) | 3.41482964 |
| 82 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.41073401 |
| 83 | regulation of interleukin-17 production (GO:0032660) | 3.39648576 |
| 84 | macrophage activation involved in immune response (GO:0002281) | 3.37799480 |
| 85 | positive regulation of interleukin-10 production (GO:0032733) | 3.36460702 |
| 86 | B cell mediated immunity (GO:0019724) | 3.36156722 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.35005370 |
| 88 | respiratory burst (GO:0045730) | 3.33837911 |
| 89 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33826697 |
| 90 | dendritic cell chemotaxis (GO:0002407) | 3.32317701 |
| 91 | microglial cell activation (GO:0001774) | 3.31218229 |
| 92 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.31036167 |
| 93 | regulation of leukocyte degranulation (GO:0043300) | 3.30296293 |
| 94 | response to host immune response (GO:0052572) | 3.29482057 |
| 95 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29482057 |
| 96 | T cell migration (GO:0072678) | 3.28284854 |
| 97 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.27202790 |
| 98 | negative regulation of viral genome replication (GO:0045071) | 3.26887168 |
| 99 | positive regulation of T cell cytokine production (GO:0002726) | 3.26689608 |
| 100 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.22780479 |
| 101 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.21491374 |
| 102 | regulation of monocyte chemotaxis (GO:0090025) | 3.20985947 |
| 103 | * myeloid dendritic cell differentiation (GO:0043011) | 3.17210957 |
| 104 | leukocyte mediated cytotoxicity (GO:0001909) | 3.17000421 |
| 105 | negative T cell selection (GO:0043383) | 3.15465732 |
| 106 | positive regulation of interleukin-17 production (GO:0032740) | 3.14941004 |
| 107 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.14495114 |
| 108 | positive regulation of response to biotic stimulus (GO:0002833) | 3.13144640 |
| 109 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.13027892 |
| 110 | response to protozoan (GO:0001562) | 3.12010271 |
| 111 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.11688701 |
| 112 | * regulation of T-helper cell differentiation (GO:0045622) | 3.11234838 |
| 113 | * regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.10674969 |
| 114 | regulation of mononuclear cell migration (GO:0071675) | 3.08262699 |
| 115 | response to interferon-alpha (GO:0035455) | 3.08249838 |
| 116 | * response to interferon-gamma (GO:0034341) | 3.07369074 |
| 117 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.06979819 |
| 118 | myeloid cell activation involved in immune response (GO:0002275) | 3.06892910 |
| 119 | cellular response to interferon-gamma (GO:0071346) | 3.06586168 |
| 120 | natural killer cell differentiation (GO:0001779) | 3.06468988 |
| 121 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.05222950 |
| 122 | eosinophil migration (GO:0072677) | 3.04900104 |
| 123 | dendritic cell migration (GO:0036336) | 3.04544114 |
| 124 | * myeloid dendritic cell activation (GO:0001773) | 3.04207787 |
| 125 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.03515245 |
| 126 | positive regulation of macrophage cytokine production (GO:0060907) | 3.02937104 |
| 127 | glycosphingolipid catabolic process (GO:0046479) | 3.02675537 |
| 128 | response to interferon-beta (GO:0035456) | 3.02355537 |
| 129 | * positive regulation of interleukin-2 production (GO:0032743) | 3.01250276 |
| 130 | * positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.01150760 |
| 131 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.00856920 |
| 132 | positive regulation of B cell differentiation (GO:0045579) | 3.00369314 |
| 133 | positive regulation of humoral immune response (GO:0002922) | 2.99720859 |
| 134 | lymphocyte chemotaxis (GO:0048247) | 2.96844296 |
| 135 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93244583 |
| 136 | response to host (GO:0075136) | 2.93244583 |
| 137 | response to host defenses (GO:0052200) | 2.93244583 |
| 138 | regulation of macrophage chemotaxis (GO:0010758) | 2.91778945 |
| 139 | negative regulation of T cell mediated immunity (GO:0002710) | 2.88902868 |
| 140 | germinal center formation (GO:0002467) | 2.88217650 |
| 141 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87259306 |
| 142 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.86113630 |
| 143 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82132061 |
| 144 | B cell receptor signaling pathway (GO:0050853) | 2.81707507 |
| 145 | positive regulation of B cell mediated immunity (GO:0002714) | 2.80454701 |
| 146 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.80454701 |
| 147 | amino sugar catabolic process (GO:0046348) | 2.79306185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.28435938 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.45230411 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.43941871 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.40842830 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.32398258 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.19666358 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.57520008 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.72203531 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.39902670 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.30653819 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.26144334 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.16589189 |
| 13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.12100630 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06547469 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.95803732 |
| 16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.85649594 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34419313 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34128236 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.18540807 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01543710 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.98407107 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96959502 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.90893021 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85169051 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.81187114 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78071566 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68530073 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.62585434 |
| 29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62504760 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61784613 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.60983063 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57093588 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56465583 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54795157 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52147582 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51983504 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.50970945 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.49760728 |
| 39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48347782 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46294978 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45835978 |
| 42 | * MYB_26560356_Chip-Seq_TH1_Human | 1.44491405 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40769896 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35773610 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32656463 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32348728 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27384860 |
| 48 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26590386 |
| 49 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25414978 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25198856 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23157005 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22204307 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21119881 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19805829 |
| 55 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18735181 |
| 56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17029052 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15202239 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14106477 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13517853 |
| 60 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.12642388 |
| 61 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12259693 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11980009 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08716470 |
| 64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01116300 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00940116 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00638254 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99094646 |
| 68 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98533564 |
| 69 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98168364 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95716543 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95328230 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95056494 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94292316 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90194682 |
| 75 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89851561 |
| 76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88825101 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87395036 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87259729 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86917043 |
| 80 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86074826 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86025226 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85815635 |
| 83 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84826515 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83949761 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83586518 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.81671268 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 0.80066133 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79466160 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77123888 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73638277 |
| 91 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72359995 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72359995 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72292675 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71400049 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70197403 |
| 96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.70018917 |
| 97 | UTX_26944678_Chip-Seq_JUKART_Human | 0.69440862 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69062594 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.68328267 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66225477 |
| 101 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.66177106 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.66156103 |
| 103 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.64306019 |
| 104 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.63371038 |
| 105 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.61467344 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60743712 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.60608364 |
| 108 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58599760 |
| 109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55047132 |
| 110 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.54389529 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.54352116 |
| 112 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.54352116 |
| 113 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.54072207 |
| 114 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.54017266 |
| 115 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.52678346 |
| 116 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.52462038 |
| 117 | CJUN_26792858_Chip-Seq_BT549_Human | 0.51746080 |
| 118 | GATA3_26560356_Chip-Seq_TH1_Human | 0.51405733 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.50706701 |
| 120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.50471805 |
| 121 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.49799164 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.49540991 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.49010229 |
| 124 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.48995120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.24575205 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.30285694 |
| 3 | MP0000685_abnormal_immune_system | 3.99334671 |
| 4 | MP0005671_abnormal_response_to | 3.82947191 |
| 5 | MP0009785_altered_susceptibility_to | 3.82353639 |
| 6 | MP0001790_abnormal_immune_system | 3.55330075 |
| 7 | MP0005387_immune_system_phenotype | 3.55330075 |
| 8 | MP0003436_decreased_susceptibility_to | 3.51104167 |
| 9 | * MP0005000_abnormal_immune_tolerance | 3.35293149 |
| 10 | MP0005025_abnormal_response_to | 3.03843603 |
| 11 | * MP0001800_abnormal_humoral_immune | 2.92652290 |
| 12 | MP0006082_CNS_inflammation | 2.92561555 |
| 13 | MP0002419_abnormal_innate_immunity | 2.91508063 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.86311595 |
| 15 | MP0004510_myositis | 2.86268714 |
| 16 | * MP0002723_abnormal_immune_serum | 2.76590916 |
| 17 | MP0003724_increased_susceptibility_to | 2.55735165 |
| 18 | * MP0001819_abnormal_immune_cell | 2.47480767 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.41875023 |
| 20 | MP0002163_abnormal_gland_morphology | 2.36873520 |
| 21 | MP0005310_abnormal_salivary_gland | 2.28033522 |
| 22 | MP0001853_heart_inflammation | 2.24269010 |
| 23 | MP0001348_abnormal_lacrimal_gland | 2.20806231 |
| 24 | MP0003303_peritoneal_inflammation | 2.10818392 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.09341358 |
| 26 | MP0002006_tumorigenesis | 2.05818338 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.96824770 |
| 28 | * MP0000716_abnormal_immune_system | 1.83110860 |
| 29 | MP0002405_respiratory_system_inflammati | 1.82078311 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.81140061 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.79390926 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.78156286 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.77148088 |
| 34 | MP0009764_decreased_sensitivity_to | 1.76031944 |
| 35 | * MP0002398_abnormal_bone_marrow | 1.73348009 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.67846830 |
| 37 | MP0005451_abnormal_body_composition | 1.64377366 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.62347431 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.58765006 |
| 40 | * MP0008469_abnormal_protein_level | 1.51046582 |
| 41 | MP0004947_skin_inflammation | 1.48602674 |
| 42 | MP0001346_abnormal_lacrimal_gland | 1.47912996 |
| 43 | MP0002254_reproductive_system_inflammat | 1.46526895 |
| 44 | * MP0002429_abnormal_blood_cell | 1.40828516 |
| 45 | MP0003448_altered_tumor_morphology | 1.40526145 |
| 46 | MP0005379_endocrine/exocrine_gland_phen | 1.36876448 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.35692656 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.30936243 |
| 49 | MP0003075_altered_response_to | 1.30130893 |
| 50 | * MP0000689_abnormal_spleen_morphology | 1.28296111 |
| 51 | MP0008260_abnormal_autophagy | 1.28111876 |
| 52 | MP0009840_abnormal_foam_cell | 1.26615692 |
| 53 | MP0002722_abnormal_immune_system | 1.25581157 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.20653755 |
| 55 | MP0008004_abnormal_stomach_pH | 1.17458127 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.14447005 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.11980216 |
| 58 | MP0000858_altered_metastatic_potential | 1.06199019 |
| 59 | MP0000343_altered_response_to | 1.05041535 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.04805963 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.03521102 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 1.00229102 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.00229102 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 0.97913485 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 0.97200436 |
| 66 | MP0009763_increased_sensitivity_to | 0.90826809 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 0.90567267 |
| 68 | MP0003690_abnormal_glial_cell | 0.88848418 |
| 69 | * MP0000920_abnormal_myelination | 0.84545649 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.84519763 |
| 71 | MP0008057_abnormal_DNA_replication | 0.83808676 |
| 72 | MP0005174_abnormal_tail_pigmentation | 0.79966792 |
| 73 | MP0001851_eye_inflammation | 0.79724675 |
| 74 | MP0005166_decreased_susceptibility_to | 0.79608477 |
| 75 | MP0001663_abnormal_digestive_system | 0.78186360 |
| 76 | MP0005390_skeleton_phenotype | 0.77607685 |
| 77 | MP0010307_abnormal_tumor_latency | 0.74933481 |
| 78 | MP0000249_abnormal_blood_vessel | 0.73986614 |
| 79 | MP0003186_abnormal_redox_activity | 0.73852992 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.70534238 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.70208026 |
| 82 | MP0002332_abnormal_exercise_endurance | 0.69497723 |
| 83 | MP0003795_abnormal_bone_structure | 0.68702183 |
| 84 | MP0001873_stomach_inflammation | 0.68491931 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.68428767 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.68224928 |
| 87 | MP0002933_joint_inflammation | 0.67438904 |
| 88 | MP0003091_abnormal_cell_migration | 0.64966326 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.64827124 |
| 90 | MP0005165_increased_susceptibility_to | 0.64252359 |
| 91 | MP0003329_amyloid_beta_deposits | 0.64042451 |
| 92 | MP0003300_gastrointestinal_ulcer | 0.63852977 |
| 93 | MP0006054_spinal_hemorrhage | 0.63243227 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.62234301 |
| 95 | MP0002132_abnormal_respiratory_system | 0.62153956 |
| 96 | MP0005164_abnormal_response_to | 0.61900938 |
| 97 | MP0008874_decreased_physiological_sensi | 0.61619303 |
| 98 | MP0009278_abnormal_bone_marrow | 0.60923834 |
| 99 | MP0003195_calcinosis | 0.60627563 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.59793710 |
| 101 | MP0003828_pulmonary_edema | 0.59717957 |
| 102 | MP0000604_amyloidosis | 0.59466442 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.59089737 |
| 104 | MP0000371_diluted_coat_color | 0.58928500 |
| 105 | MP0002009_preneoplasia | 0.58559379 |
| 106 | MP0003045_fibrosis | 0.58380429 |
| 107 | MP0005647_abnormal_sex_gland | 0.57944720 |
| 108 | MP0000767_abnormal_smooth_muscle | 0.56752537 |
| 109 | MP0003866_abnormal_defecation | 0.56135169 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.53712271 |
| 111 | MP0000609_abnormal_liver_physiology | 0.53040563 |
| 112 | MP0004883_abnormal_blood_vessel | 0.52697324 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.52602078 |
| 114 | MP0001881_abnormal_mammary_gland | 0.48704573 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.48049387 |
| 116 | MP0000627_abnormal_mammary_gland | 0.46192389 |
| 117 | MP0001915_intracranial_hemorrhage | 0.46092551 |
| 118 | MP0002396_abnormal_hematopoietic_system | 0.44039214 |
| 119 | MP0000490_abnormal_crypts_of | 0.40906116 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.40225057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.55647901 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.29382942 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.23045787 |
| 4 | Increased IgM level (HP:0003496) | 5.25369749 |
| 5 | Optic neuritis (HP:0100653) | 5.19873100 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.19873100 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.91387696 |
| 8 | Orchitis (HP:0100796) | 4.89892644 |
| 9 | Myositis (HP:0100614) | 4.86653486 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 4.76800518 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.76357287 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.57301703 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.54816575 |
| 14 | Vasculitis (HP:0002633) | 4.25475716 |
| 15 | Abnormality of macrophages (HP:0004311) | 4.16064480 |
| 16 | Recurrent skin infections (HP:0001581) | 4.11133456 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.01640021 |
| 18 | Basal ganglia calcification (HP:0002135) | 3.81037444 |
| 19 | Recurrent viral infections (HP:0004429) | 3.69993323 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.56887459 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.54504127 |
| 22 | Disinhibition (HP:0000734) | 3.53058153 |
| 23 | Gingivitis (HP:0000230) | 3.52312461 |
| 24 | Loss of speech (HP:0002371) | 3.50593950 |
| 25 | Chronic otitis media (HP:0000389) | 3.48802631 |
| 26 | Hypergammaglobulinemia (HP:0010702) | 3.39089376 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.35696348 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.35696348 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.34841003 |
| 30 | Agammaglobulinemia (HP:0004432) | 3.32954094 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.28854152 |
| 32 | Obstructive lung disease (HP:0006536) | 3.28854152 |
| 33 | Meningitis (HP:0001287) | 3.22749657 |
| 34 | Arterial thrombosis (HP:0004420) | 3.22100654 |
| 35 | Glomerulonephritis (HP:0000099) | 3.12725426 |
| 36 | Keratoconjunctivitis sicca (HP:0001097) | 3.10944334 |
| 37 | Cellulitis (HP:0100658) | 3.06901498 |
| 38 | Recurrent pneumonia (HP:0006532) | 3.01582427 |
| 39 | Amyloidosis (HP:0011034) | 3.00248841 |
| 40 | Periodontitis (HP:0000704) | 2.99833201 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.99497475 |
| 42 | Stomatitis (HP:0010280) | 2.98871458 |
| 43 | Thick nail (HP:0001805) | 2.95967901 |
| 44 | Pustule (HP:0200039) | 2.93620925 |
| 45 | Mutism (HP:0002300) | 2.93531383 |
| 46 | Keratoconjunctivitis (HP:0001096) | 2.87873283 |
| 47 | Eosinophilia (HP:0001880) | 2.85035862 |
| 48 | Recurrent lower respiratory tract infections (HP:0002783) | 2.83023015 |
| 49 | T lymphocytopenia (HP:0005403) | 2.77027115 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.75665962 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.75665962 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.75665962 |
| 53 | Colitis (HP:0002583) | 2.75144442 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.71971780 |
| 55 | Osteolytic defects of the hand bones (HP:0009699) | 2.70205582 |
| 56 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.70205582 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.69232079 |
| 58 | Leukocytosis (HP:0001974) | 2.67840880 |
| 59 | Mucopolysacchariduria (HP:0008155) | 2.65587532 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65587532 |
| 61 | Hemoptysis (HP:0002105) | 2.64377253 |
| 62 | Recurrent bronchitis (HP:0002837) | 2.63766332 |
| 63 | Encephalitis (HP:0002383) | 2.61935946 |
| 64 | Interstitial pulmonary disease (HP:0006530) | 2.59062823 |
| 65 | Osteomyelitis (HP:0002754) | 2.58646908 |
| 66 | Myocardial infarction (HP:0001658) | 2.55789712 |
| 67 | Abnormality of the prostate (HP:0008775) | 2.54581737 |
| 68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.54337353 |
| 69 | Urticaria (HP:0001025) | 2.53195411 |
| 70 | Axonal loss (HP:0003447) | 2.50008125 |
| 71 | Prostate neoplasm (HP:0100787) | 2.49388466 |
| 72 | Joint swelling (HP:0001386) | 2.48075519 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 2.47221066 |
| 74 | Granulocytopenia (HP:0001913) | 2.46033155 |
| 75 | IgA deficiency (HP:0002720) | 2.45651983 |
| 76 | Increased cerebral lipofuscin (HP:0011813) | 2.41046626 |
| 77 | Panhypogammaglobulinemia (HP:0003139) | 2.40488987 |
| 78 | Polyneuropathy (HP:0001271) | 2.39578679 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.38798526 |
| 80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.38798526 |
| 81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.38798526 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.38367808 |
| 83 | Tetraparesis (HP:0002273) | 2.36995334 |
| 84 | Gingival bleeding (HP:0000225) | 2.35958970 |
| 85 | Porencephaly (HP:0002132) | 2.32773978 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 2.32592225 |
| 87 | IgG deficiency (HP:0004315) | 2.32298401 |
| 88 | Abnormality of eosinophils (HP:0001879) | 2.31931662 |
| 89 | Pulmonary embolism (HP:0002204) | 2.31448446 |
| 90 | Increased serum ferritin (HP:0003281) | 2.28741452 |
| 91 | Abnormality of the pleura (HP:0002103) | 2.28443917 |
| 92 | Abnormality of T cells (HP:0002843) | 2.27283959 |
| 93 | Agnosia (HP:0010524) | 2.26414620 |
| 94 | Chronic sinusitis (HP:0011109) | 2.26129267 |
| 95 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.25861629 |
| 96 | Chronic diarrhea (HP:0002028) | 2.25502465 |
| 97 | Nasal polyposis (HP:0100582) | 2.25356474 |
| 98 | Restrictive lung disease (HP:0002091) | 2.24389793 |
| 99 | Petechiae (HP:0000967) | 2.22463130 |
| 100 | Anorexia (HP:0002039) | 2.22181821 |
| 101 | Gangrene (HP:0100758) | 2.21944512 |
| 102 | Epistaxis (HP:0000421) | 2.19788848 |
| 103 | Hepatosplenomegaly (HP:0001433) | 2.19779928 |
| 104 | Spontaneous hematomas (HP:0007420) | 2.19672048 |
| 105 | Nephritis (HP:0000123) | 2.19588571 |
| 106 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19016405 |
| 107 | Arthralgia (HP:0002829) | 2.17386413 |
| 108 | Thrombocytosis (HP:0001894) | 2.16964649 |
| 109 | Amaurosis fugax (HP:0100576) | 2.16584103 |
| 110 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.16364683 |
| 111 | Neurofibrillary tangles (HP:0002185) | 2.16198070 |
| 112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15982227 |
| 113 | Gastrointestinal inflammation (HP:0004386) | 2.15787366 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 2.14049765 |
| 115 | Purpura (HP:0000979) | 2.11469356 |
| 116 | Hypochromic anemia (HP:0001931) | 2.11042648 |
| 117 | Thyroiditis (HP:0100646) | 2.10395041 |
| 118 | Abnormality of complement system (HP:0005339) | 2.08553174 |
| 119 | Glomerulopathy (HP:0100820) | 2.07821651 |
| 120 | Dysostosis multiplex (HP:0000943) | 2.06675068 |
| 121 | Chest pain (HP:0100749) | 2.06079974 |
| 122 | Diminished motivation (HP:0000745) | 2.06000821 |
| 123 | Apathy (HP:0000741) | 2.05083115 |
| 124 | Memory impairment (HP:0002354) | 2.03395436 |
| 125 | Increased IgE level (HP:0003212) | 2.02740034 |
| 126 | Vertebral compression fractures (HP:0002953) | 2.02688338 |
| 127 | Progressive neurologic deterioration (HP:0002344) | 2.02605080 |
| 128 | Abnormality of the pericardium (HP:0001697) | 1.99791123 |
| 129 | Premature loss of primary teeth (HP:0006323) | 1.99423280 |
| 130 | Upper motor neuron abnormality (HP:0002127) | 1.99192821 |
| 131 | Hematochezia (HP:0002573) | 1.98372545 |
| 132 | Inappropriate behavior (HP:0000719) | 1.95380685 |
| 133 | Vertigo (HP:0002321) | 1.94590647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.85014698 |
| 2 | BLK | 3.66777373 |
| 3 | TBK1 | 3.60020274 |
| 4 | TYK2 | 3.45909931 |
| 5 | IRAK4 | 3.35683295 |
| 6 | IKBKB | 3.34496964 |
| 7 | RIPK4 | 3.08471305 |
| 8 | IKBKE | 2.93768284 |
| 9 | JAK3 | 2.71363496 |
| 10 | MAP3K13 | 2.61817054 |
| 11 | MAP4K1 | 2.36391666 |
| 12 | IRAK3 | 2.28792353 |
| 13 | JAK1 | 2.28309333 |
| 14 | BMPR2 | 2.26927802 |
| 15 | PRPF4B | 2.18871548 |
| 16 | PIM2 | 2.11996207 |
| 17 | CHUK | 2.06655829 |
| 18 | PBK | 1.99628676 |
| 19 | TXK | 1.93410017 |
| 20 | MST4 | 1.82633234 |
| 21 | SYK | 1.77349793 |
| 22 | KIT | 1.73131423 |
| 23 | EPHB1 | 1.61733053 |
| 24 | BTK | 1.53836821 |
| 25 | TGFBR2 | 1.52813701 |
| 26 | CSF1R | 1.52729445 |
| 27 | HCK | 1.39910086 |
| 28 | ZAP70 | 1.36546781 |
| 29 | TAOK2 | 1.35751711 |
| 30 | GRK7 | 1.33837933 |
| 31 | MAP3K3 | 1.33279867 |
| 32 | TEC | 1.33160763 |
| 33 | ARAF | 1.30928074 |
| 34 | EIF2AK2 | 1.30172809 |
| 35 | NME2 | 1.29544041 |
| 36 | PIM1 | 1.25275633 |
| 37 | LYN | 1.25075965 |
| 38 | CSK | 1.24337667 |
| 39 | NEK9 | 1.24334814 |
| 40 | JAK2 | 1.09098240 |
| 41 | BCR | 1.07451106 |
| 42 | TAOK1 | 1.05814848 |
| 43 | LCK | 1.04176980 |
| 44 | FGFR4 | 1.02556904 |
| 45 | CDC42BPA | 1.01717063 |
| 46 | EPHA3 | 1.00359032 |
| 47 | TNK2 | 1.00156750 |
| 48 | FGFR3 | 0.99483273 |
| 49 | ITK | 0.94423899 |
| 50 | CAMKK2 | 0.91993682 |
| 51 | DDR2 | 0.91005258 |
| 52 | ADRBK2 | 0.90369597 |
| 53 | YES1 | 0.88714430 |
| 54 | IRAK1 | 0.84827443 |
| 55 | PKN1 | 0.83468172 |
| 56 | SIK3 | 0.83324567 |
| 57 | PRKCQ | 0.82908393 |
| 58 | MATK | 0.81725570 |
| 59 | ABL2 | 0.80324492 |
| 60 | TRPM7 | 0.78136660 |
| 61 | PDK1 | 0.76855164 |
| 62 | PRKCD | 0.75637975 |
| 63 | STK4 | 0.74375504 |
| 64 | STK10 | 0.73999780 |
| 65 | ERN1 | 0.71074213 |
| 66 | TAOK3 | 0.70534213 |
| 67 | PDPK1 | 0.70062572 |
| 68 | TESK2 | 0.66882611 |
| 69 | STK24 | 0.66815669 |
| 70 | CDK19 | 0.66280038 |
| 71 | BMX | 0.66144667 |
| 72 | CAMK1D | 0.66078177 |
| 73 | MOS | 0.65916586 |
| 74 | FES | 0.65406840 |
| 75 | MAPK7 | 0.65393443 |
| 76 | MAPKAPK2 | 0.60461382 |
| 77 | ABL1 | 0.59469932 |
| 78 | MAPK12 | 0.56733648 |
| 79 | MARK3 | 0.56291034 |
| 80 | RPS6KA4 | 0.54071936 |
| 81 | FYN | 0.53947832 |
| 82 | IRAK2 | 0.53561565 |
| 83 | BMPR1B | 0.53161078 |
| 84 | SIK2 | 0.50408020 |
| 85 | PDK2 | 0.49894689 |
| 86 | RAF1 | 0.48538751 |
| 87 | CLK1 | 0.48160372 |
| 88 | TESK1 | 0.46489534 |
| 89 | RPS6KL1 | 0.42292381 |
| 90 | RPS6KC1 | 0.42292381 |
| 91 | FGR | 0.42222589 |
| 92 | EGFR | 0.41912384 |
| 93 | STK3 | 0.38765152 |
| 94 | KSR2 | 0.37274801 |
| 95 | DAPK2 | 0.36782674 |
| 96 | ERBB3 | 0.36419738 |
| 97 | CDK4 | 0.36308805 |
| 98 | PTK6 | 0.36280416 |
| 99 | RPS6KA5 | 0.36140984 |
| 100 | NLK | 0.35865761 |
| 101 | GRK6 | 0.35439488 |
| 102 | LRRK2 | 0.34293604 |
| 103 | MAPK4 | 0.33937967 |
| 104 | NUAK1 | 0.32950663 |
| 105 | PIK3CG | 0.32472525 |
| 106 | MARK2 | 0.29973591 |
| 107 | RIPK1 | 0.29875660 |
| 108 | HIPK2 | 0.28199677 |
| 109 | IGF1R | 0.26419432 |
| 110 | MAP3K5 | 0.24976783 |
| 111 | WNK1 | 0.24791164 |
| 112 | MAP2K3 | 0.24331683 |
| 113 | CAMKK1 | 0.23144595 |
| 114 | RPS6KA2 | 0.21762634 |
| 115 | MAP3K8 | 0.20940763 |
| 116 | FLT3 | 0.18459723 |
| 117 | RPS6KA1 | 0.18379163 |
| 118 | INSR | 0.18041964 |
| 119 | PRKCE | 0.17455860 |
| 120 | ACVR1B | 0.17320142 |
| 121 | MAP3K11 | 0.16508517 |
| 122 | CDK6 | 0.16408235 |
| 123 | RPS6KA6 | 0.14215506 |
| 124 | MAP2K6 | 0.14092521 |
| 125 | MAP3K12 | 0.13619047 |
| 126 | MAP3K1 | 0.13298070 |
| 127 | DYRK1B | 0.13163918 |
| 128 | MST1R | 0.12992426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Allograft rejection_Homo sapiens_hsa05330 | 3.66677095 |
| 2 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 3.14721535 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04059094 |
| 4 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.90263368 |
| 5 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.85398596 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.81652142 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.76964129 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.60209304 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.48299384 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.45413169 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.30370147 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27046164 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.20147321 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15534118 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.09324607 |
| 16 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08610808 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 2.07835238 |
| 18 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06803755 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 2.05485499 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.97100708 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.90654701 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88285992 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.86106843 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.84891634 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.84042571 |
| 26 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.82796798 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.79235985 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.79177436 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.78795795 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.71083614 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.69004923 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.57369789 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55124179 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.50120378 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.40702610 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37773018 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.34946752 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.32614772 |
| 39 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.32566544 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.30450979 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18098740 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.17472087 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.13483290 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08078842 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01747778 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.01630925 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96887147 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96847450 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92805241 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.84059604 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81552992 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74492446 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73264281 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72306470 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71596800 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70295817 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69950859 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69252588 |
| 59 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69069384 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65298737 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.60345222 |
| 62 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58475813 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54446749 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54190436 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54059371 |
| 66 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53597345 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52682601 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.49564128 |
| 69 | Proteasome_Homo sapiens_hsa03050 | 0.45093816 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44176767 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42453659 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37259354 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35099648 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34918109 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.32621456 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31590291 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31520876 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31329266 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31040309 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27944122 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27747434 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26177627 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25159988 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21844447 |
| 85 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.21842533 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21419726 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20739435 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18245522 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17945520 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17883464 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17864904 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17541289 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17035291 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16375933 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16072539 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.15948960 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.15301967 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.14161912 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14075912 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.13792560 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11674871 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.11484756 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.10729400 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10485440 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10296021 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.10059298 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.09519922 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08889888 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.06526085 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.06309127 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.06262012 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.05629674 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.04317999 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.04317766 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.02851179 |

